Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL

Angela Doran, R. Scott Obach, Bill J. Smith, Natilie A. Hosea, Stacey Becker, Ernesto Callegari, Cuiping Chen, Xi Chen, Edna Choo, Julie Cianfrogna, Loretta M. Cox, John P. Gibbs, Megan A. Gibbs, Heather Hatch, Cornelis E.C.A. Hop, Ilana N. Kasman, Jennifer LaPerle, JianHua Liu, Xingrong Liu, Michael Logman, Debra Maclin, Frank M. Nedza, Frederick Nelson, Emily Olson, Sandhya Rahematpura, David Raunig, Sabrinia Rogers, Kari Schmidt, Douglas K. Spracklin, Mark Szewc, Matthew Troutman, Elaine Tseng, Meihua Tu, Jeffrey W. Van Deusen, Karthik Venkatakrishnan, Gary Walens, Ellen Q. Wang, Diane Wong, Adam S. Yasgar and Chenghong Zhang
Drug Metabolism and Disposition January 2005, 33 (1) 165-174; DOI: https://doi.org/10.1124/dmd.104.001230
Angela Doran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Scott Obach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bill J. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natilie A. Hosea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Becker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernesto Callegari
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cuiping Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xi Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edna Choo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Cianfrogna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loretta M. Cox
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Gibbs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan A. Gibbs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Hatch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cornelis E.C.A. Hop
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ilana N. Kasman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer LaPerle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JianHua Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xingrong Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Logman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debra Maclin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank M. Nedza
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick Nelson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Olson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandhya Rahematpura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Raunig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrinia Rogers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari Schmidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas K. Spracklin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Szewc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Troutman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Tseng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meihua Tu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey W. Van Deusen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karthik Venkatakrishnan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Walens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen Q. Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Wong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam S. Yasgar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chenghong Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Thirty-two structurally diverse drugs used for the treatment of various conditions of the central nervous system (CNS), along with two active metabolites, and eight non-CNS drugs were measured in brain, plasma, and cerebrospinal fluid in the P-glycoprotein (P-gp) knockout mouse model after subcutaneous administration, and the data were compared with corresponding data obtained in wild-type mice. Total brain-to-plasma (B/P) ratios for the CNS agents ranged from 0.060 to 24. Of the 34 CNS-active agents, only 7 demonstrated B/P area under the plasma concentration curve ratios between P-gp knockout and wild-type mice that did not differ significantly from unity. Most of the remaining drugs demonstrated 1.1- to 2.6-fold greater B/P ratios in P-gp knockout mice versus wild-type mice. Three, risperidone, its active metabolite 9-hydroxyrisperidone, and metoclopramide, showed marked differences in B/P ratios between knockout and wild-type mice (6.6- to 17-fold). Differences in B/P ratios and cerebrospinal fluid/plasma ratios between wild-type and knockout animals were correlated. Through the use of this model, it appears that most CNS-active agents demonstrate at least some P-gp-mediated transport that can affect brain concentrations. However, the impact for the majority of agents is probably minor. The example of risperidone illustrates that even good P-gp substrates can still be clinically useful CNS-active agents. However, for such agents, unbound plasma concentrations may need to be greater than values projected using receptor affinity data to achieve adequate receptor occupancy for effect.

Footnotes

  • doi:10.1124/dmd.104.001230.

  • ABBREVIATIONS: MDCK, Madin-Darby canine kidney; B/P, brain-to-plasma ratio; AUC, area under the plasma concentration curve; CSF/P, cerebrospinal fluid-to-plasma ratio; CSF, cerebrospinal fluid; CNS, central nervous system; P-gp, P-glycoprotein; HPLC, high-performance liquid chromatography; WT, wild type; KO, knockout.

    • Received June 29, 2004.
    • Accepted October 20, 2004.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (1)
Drug Metabolism and Disposition
Vol. 33, Issue 1
1 Jan 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL

Angela Doran, R. Scott Obach, Bill J. Smith, Natilie A. Hosea, Stacey Becker, Ernesto Callegari, Cuiping Chen, Xi Chen, Edna Choo, Julie Cianfrogna, Loretta M. Cox, John P. Gibbs, Megan A. Gibbs, Heather Hatch, Cornelis E.C.A. Hop, Ilana N. Kasman, Jennifer LaPerle, JianHua Liu, Xingrong Liu, Michael Logman, Debra Maclin, Frank M. Nedza, Frederick Nelson, Emily Olson, Sandhya Rahematpura, David Raunig, Sabrinia Rogers, Kari Schmidt, Douglas K. Spracklin, Mark Szewc, Matthew Troutman, Elaine Tseng, Meihua Tu, Jeffrey W. Van Deusen, Karthik Venkatakrishnan, Gary Walens, Ellen Q. Wang, Diane Wong, Adam S. Yasgar and Chenghong Zhang
Drug Metabolism and Disposition January 1, 2005, 33 (1) 165-174; DOI: https://doi.org/10.1124/dmd.104.001230

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL

Angela Doran, R. Scott Obach, Bill J. Smith, Natilie A. Hosea, Stacey Becker, Ernesto Callegari, Cuiping Chen, Xi Chen, Edna Choo, Julie Cianfrogna, Loretta M. Cox, John P. Gibbs, Megan A. Gibbs, Heather Hatch, Cornelis E.C.A. Hop, Ilana N. Kasman, Jennifer LaPerle, JianHua Liu, Xingrong Liu, Michael Logman, Debra Maclin, Frank M. Nedza, Frederick Nelson, Emily Olson, Sandhya Rahematpura, David Raunig, Sabrinia Rogers, Kari Schmidt, Douglas K. Spracklin, Mark Szewc, Matthew Troutman, Elaine Tseng, Meihua Tu, Jeffrey W. Van Deusen, Karthik Venkatakrishnan, Gary Walens, Ellen Q. Wang, Diane Wong, Adam S. Yasgar and Chenghong Zhang
Drug Metabolism and Disposition January 1, 2005, 33 (1) 165-174; DOI: https://doi.org/10.1124/dmd.104.001230
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Summary
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Endogenous substrates of rat organic cation transporters
  • Catabolism and Metabolism of ABBV-011, a Calicheamicin ADC
  • Gadoxetate-enhanced MRI and FXR in benign tumours
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics